Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Feb 6, 2014
Fiscal second quarter net sales increased 11% year-over-year to a record $979 million. Fiscal second quarter adjusted net income increased 45% to a record $185...
-
Jan 29, 2014
Perrigo Company plc (NYSE: PRGO; TASE) today announced that its Board of Directors declared a quarterly dividend of $0.105 per share, payable on March 18,...
-
Jan 24, 2014
Perrigo Company plc (NYSE: PRGO; TASE) today announced that it has received final approval from the U.S. Food & Drug Administration (FDA) for its abbreviated...
-
Jan 23, 2014
Perrigo Company plc (NYSE: PRGO; TASE) today announced that it will release financial results for its second quarter fiscal year 2014 on Thursday, February...
-
Jan 14, 2014
Perrigo Company (NYSE: PRGO; TASE) today announced that it has received final approval for its abbreviated new drug application ("ANDA") for fluocinonide...
-
Jan 8, 2014
Perrigo Company plc (NYSE: PRGO; TASE) today announced that it will hold its Investor Day from 8:00 AM to approximately 12:00 PM EST on February 28, at the...
-
Dec 18, 2013
Perrigo Company plc (NYSE: PRGO) today announced the appointment of its Board of Directors, effective until Perrigo Company's annual general meeting...
-
Dec 18, 2013
Perrigo Company plc (NYSE, TASE: PRGO) ("Perrigo") and Elan Corporation, plc ("Elan") today announced that Perrigo has completed the acquisition of Elan in a...
-
Dec 13, 2013
Perrigo Company (NYSE: PRGO; TASE) and Elan Corporation, plc (NYSE: ELN) ("Elan") today announced that the Irish High Court has approved...
-
Nov 21, 2013
Perrigo Company (NYSE, TASE: PRGO) today announced that, in connection with its offer to purchase for cash (the "Tender Offer") any and all of its...